P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 430 000 KRW -4.76% Market Closed
Market Cap: 4.5T KRW

Intrinsic Value

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 430 000 KRW, PharmaResearch Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PharmaResearch Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
PharmaResearch Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

PharmaResearch Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if PharmaResearch Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PharmaResearch Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PharmaResearch Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PharmaResearch Co Ltd.

Explain Valuation
Compare PharmaResearch Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PharmaResearch Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaResearch Co Ltd

Current Assets 691.6B
Cash & Short-Term Investments 539.2B
Receivables 70.9B
Other Current Assets 81.6B
Non-Current Assets 296.7B
Long-Term Investments 86.5B
PP&E 166.6B
Intangibles 33.8B
Other Non-Current Assets 9.8B
Current Liabilities 92B
Accounts Payable 12B
Other Current Liabilities 80B
Non-Current Liabilities 235.3B
Long-Term Debt 201.5B
Other Non-Current Liabilities 33.8B
Efficiency

Free Cash Flow Analysis
PharmaResearch Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PharmaResearch Co Ltd

Revenue
496B KRW
Cost of Revenue
-118.6B KRW
Gross Profit
377.4B KRW
Operating Expenses
-181.9B KRW
Operating Income
195.5B KRW
Other Expenses
-44.3B KRW
Net Income
151.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaResearch Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive 3Y Average ROIC
ROIC is Increasing
Exceptional Operating Margin
hidden
Profitability
Score

PharmaResearch Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaResearch Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
hidden
Solvency
Score

PharmaResearch Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 781 632.33 KRW with a low forecast of 646 400 KRW and a high forecast of 1 245 365.21 KRW.

Lowest
Price Target
646 400 KRW
50% Upside
Average
Price Target
781 632.33 KRW
82% Upside
Highest
Price Target
1 245 365.21 KRW
190% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaResearch Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PharmaResearch Co Ltd stock?

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is hidden KRW.

Is PharmaResearch Co Ltd stock undervalued or overvalued?

Compared to the current market price of 430 000 KRW, PharmaResearch Co Ltd is hidden .

Back to Top